title: Effects of Doxorubicin, Cisplatin, and Tamoxifen on the Metabolic Profile of Human Breast Cancer MCF-7 Cells As Determined by1H High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance.
abstract: Doxorubicin (Doxo), cisplatin (Cis), and tamoxifen (Tamo) are part of many chemotherapeutic regimens. However, there have been limited studies of the way metabolism in breast cancer is affected by chemotherapy. We studied, through1H high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy, the metabolic profile of human breast cancer MCF-7 control (Con) cells as well as MCF-7 cells treated with Tamo, Cis, and Doxo.1H HR-MAS NMR single-pulse spectra evidenced signals from the cell compounds, including fatty acids (membranes), water-soluble proteins, and metabolites. The spectra showed that phosphocholine (i.e., biomarker of breast cancer malignant transformation) signals were stronger in Con than in treated cells. Betaine (i.e., the major osmolyte in cells) was observed at similar concentrations in MCF-7 control and treated cells but was absent in nontumor MCF-10A cells. The NMR spectra acquired with the Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence were used only in qualitative analyses because the signal areas were attenuated according to their transverse relaxation time (T2). The CPMG method was used to identify soluble metabolites such as organic acids, amino acids, choline and its derivatives, taurine, and guanidino acetate.1H HR-MAS NMR spectroscopy efficiently demonstrated the effects of Tamo, Cis, and Doxo on the metabolic profile of MCF-7 cells. The fatty acid, phosphocholine, and choline variations observed by single-pulse HR-MAS NMR have the potential to characterize both responder and nonresponder tumors at a molecular level.
authors.affiliation: Embrapa Instrumentação , Rua XV de Novembro, 1452, São Carlos, SP 13560-970, Brazil.
authors.forename: Roberta M
authors.identifier: 0000-0002-2390-1843
authors.initials: RM
authors.lastname: Maria
authors.affiliation: Laboratório de Bioquímica e Biologia Molecular, Departamento de Ciências Fisiológicas, Universidade Federal de São Carlos (UFSCar) , Rodovia Washington Luís, km 235, Caixa Postal 676, São Carlos, SP 13565-905, Brazil.
authors.forename: Wanessa F
authors.initials: WF
authors.lastname: Altei
authors.affiliation: Laboratório de Bioquímica e Biologia Molecular, Departamento de Ciências Fisiológicas, Universidade Federal de São Carlos (UFSCar) , Rodovia Washington Luís, km 235, Caixa Postal 676, São Carlos, SP 13565-905, Brazil.
authors.forename: Heloisa S
authors.initials: HS
authors.lastname: Selistre-de-Araujo
authors.affiliation: Embrapa Instrumentação , Rua XV de Novembro, 1452, São Carlos, SP 13560-970, Brazil.
authors.forename: Luiz A
authors.initials: LA
authors.lastname: Colnago
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D002945:Cisplatin / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D061986:MCF-7 Cells; D066244:Proton Magnetic Resonance Spectroscopy / Q000379:methods*; D013629:Tamoxifen / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D013629:Tamoxifen; D004317:Doxorubicin; D002945:Cisplatin